MedTrace Logo

Evaluation of OE-MRI in Patients With H&N Cancer

NCT04724096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-05-06

No results posted yet for this study

Summary

Assessment of the use of oxygen enhanced MRI scanning in a cohort of patients with head and neck squamous cell carcinomas to identify areas of hypoxia with tumours and relate this to treatment outcomes.

Conditions

Interventions

DIAGNOSTIC_TEST

Oxygen Enhanced MRI scan

Dynamic MRI scanning switching from breathing room air to high concentration oxygen part way through the scan.

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Rafal Panek, PhD · Nottingham University Hospitals NHS Trust

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-04
Primary Completion
2022-11-28
Completion
2023-02-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04724096 on ClinicalTrials.gov